Former Genzyme exec Vivaldi heads to Philadephia rare disease biotech

Former Genzyme executive Rogerio Vivaldi, who spent the past year overseeing the initial public offering of Minevra Neurosciences, is back to focusing on rare diseases with a new job at a Philadelphia-based biotech...